Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy

Published:2015-08 Issue: Volume:59 Page:77-87
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Jiang Kuo,Li Jia,Yin Jipeng,Ma Qiong,Yan Bo,Zhang Xiang,Wang Lei,Wang Lifeng,Liu Tao,Zhang Yinglong,Fan Qingyu,Yang Angang,Qiu Xiuchun,Ma Baoan

Funder

National Natural Science Foundation of China

State Key Program of National Natural Science of China

National Foundation of China for Infectious Diseases

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference35 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer J Int du Cancer,2015

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science (New York, NY),1989

3. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Marty;J Clin Oncol Off J Am Soc Clin Oncol,2005

4. Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer;Esteva;J Clin Oncol Off J Am Soc Clin Oncol,2002

5. Cancer and the chemokine network;Balkwill;Nat Rev Cancer,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review;Human Immunology;2024-09

2. Delivery of siRNA using hyaluronic acid‐guided nanoparticles for downregulation of CXCR4;Biopolymers;2023-03-27

3. Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer;Chemical Biology & Drug Design;2022-09-25

4. Functional Tumor Targeting Nano‐Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single‐Cell Level;Advanced Science;2022-05-20

5. Current understandings and clinical translation of nanomedicines for breast cancer therapy;Advanced Drug Delivery Reviews;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3